Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-01-28

Clinical Trial Update: Vaginal Progesterone for the Prevention of Preterm Birth in Twins [Phase 3]

View source ↗

Summary

Phase 3 trial of vaginal progesterone for preventing preterm birth in twins was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vaginal progesterone (progesterone)

Snippet

Sponsor: Chiu Yee Liona Poon | Conditions: Premature Birth, Twin Pregnancy | Phase 3 | Status: WITHDRAWN